JP2018524019A5 - - Google Patents

Download PDF

Info

Publication number
JP2018524019A5
JP2018524019A5 JP2018515195A JP2018515195A JP2018524019A5 JP 2018524019 A5 JP2018524019 A5 JP 2018524019A5 JP 2018515195 A JP2018515195 A JP 2018515195A JP 2018515195 A JP2018515195 A JP 2018515195A JP 2018524019 A5 JP2018524019 A5 JP 2018524019A5
Authority
JP
Japan
Prior art keywords
seq
molecular weight
polypeptide
isolated
high molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018515195A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018524019A (ja
JP6952685B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035858 external-priority patent/WO2016197018A1/en
Publication of JP2018524019A publication Critical patent/JP2018524019A/ja
Publication of JP2018524019A5 publication Critical patent/JP2018524019A5/ja
Priority to JP2021158128A priority Critical patent/JP7404320B2/ja
Application granted granted Critical
Publication of JP6952685B2 publication Critical patent/JP6952685B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018515195A 2015-06-05 2016-06-03 線維症の治療において使用するためのエンドスタチン断片およびバリアント Expired - Fee Related JP6952685B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021158128A JP7404320B2 (ja) 2015-06-05 2021-09-28 線維症の治療において使用するためのエンドスタチン断片およびバリアント

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562171889P 2015-06-05 2015-06-05
US62/171,889 2015-06-05
US201562257607P 2015-11-19 2015-11-19
US62/257,607 2015-11-19
PCT/US2016/035858 WO2016197018A1 (en) 2015-06-05 2016-06-03 Endostatin fragments and variants for use in treating fibrosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021158128A Division JP7404320B2 (ja) 2015-06-05 2021-09-28 線維症の治療において使用するためのエンドスタチン断片およびバリアント

Publications (3)

Publication Number Publication Date
JP2018524019A JP2018524019A (ja) 2018-08-30
JP2018524019A5 true JP2018524019A5 (enExample) 2019-07-04
JP6952685B2 JP6952685B2 (ja) 2021-10-20

Family

ID=56236074

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018515195A Expired - Fee Related JP6952685B2 (ja) 2015-06-05 2016-06-03 線維症の治療において使用するためのエンドスタチン断片およびバリアント
JP2021158128A Active JP7404320B2 (ja) 2015-06-05 2021-09-28 線維症の治療において使用するためのエンドスタチン断片およびバリアント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021158128A Active JP7404320B2 (ja) 2015-06-05 2021-09-28 線維症の治療において使用するためのエンドスタチン断片およびバリアント

Country Status (10)

Country Link
US (2) US10844392B2 (enExample)
EP (1) EP3303383A1 (enExample)
JP (2) JP6952685B2 (enExample)
KR (1) KR20180033499A (enExample)
CN (2) CN115925878A (enExample)
AU (2) AU2016270428B2 (enExample)
BR (1) BR112017026209A2 (enExample)
CA (1) CA2988299C (enExample)
WO (1) WO2016197018A1 (enExample)
ZA (1) ZA201708223B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016270428B2 (en) 2015-06-05 2020-11-26 Musc Foundation For Research Development Endostatin fragments and variants for use in treating fibrosis
AU2019338416A1 (en) * 2018-09-14 2021-04-29 Akso Biopharmaceutical, Inc. sPD-1 variant - Fc fusion proteins
EP3996736A4 (en) * 2019-07-10 2023-05-24 Musc Foundation for Research Development ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMOR, FIBROSIS AND ACUTE LUNG INJURY
EP3996694A1 (en) * 2019-07-31 2022-05-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Peptides as inhibitors of fibrotic matrix accumulation
JP7493945B2 (ja) * 2020-01-28 2024-06-03 ポーラ化成工業株式会社 培養組織の観察方法、培養方法、評価方法及び培養器具
WO2022006601A1 (en) * 2020-07-02 2022-01-06 Northwestern University Human recombinant ace2-fc mutants that decouple anti-sars-cov-2 activity from cardiovascular effects

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US750375A (en) 1904-01-26 Potato-digger
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US7045313B1 (en) 1982-11-30 2006-05-16 The United States Of America As Represented By The Department Of Health And Human Services Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
IT1164225B (it) 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5091309A (en) 1986-01-16 1992-02-25 Washington University Sindbis virus vectors
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5093258A (en) 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
US5217879A (en) 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
WO1991000916A2 (en) 1989-07-06 1991-01-24 The Regents Of The University Of California Receptors for fibroblast growth factors
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
US5756671A (en) 1994-06-02 1998-05-26 Mitotix, Inc. CDC37 cell-cycle regulatory protein, and uses related thereto
US6080560A (en) * 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
US5541087A (en) 1994-09-14 1996-07-30 Fuji Immunopharmaceuticals Corporation Expression and export technology of proteins as immunofusins
US6165460A (en) 1995-07-10 2000-12-26 Therion Biologics Corporation Generation of immune responses to prostate-specific antigen (PSA)
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
DE19535939A1 (de) 1995-09-27 1997-04-03 Agfa Gevaert Ag Fotografisches Material
WO1999029855A1 (en) 1997-12-08 1999-06-17 Beth Israel Deaconess Medical Center Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
EP1067956B1 (en) 1998-04-03 2007-03-14 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
KR20010052566A (ko) * 1998-06-03 2001-06-25 윌리엄 뉴 엔도스타틴 단백질을 포함하는 단백질 올리고머 조성물 및이의 사용방법
AU4859399A (en) 1998-07-02 2000-01-24 President And Fellows Of Harvard College Compositions and methods for treating papillomavirus-infected cells
JP2003517280A (ja) 1999-02-05 2003-05-27 トーマス・ジェファーソン・ユニバーシティ トランス相補性システムを用いての植物における生物医学用ペプチド及びタンパク質の生成
WO2000046380A2 (en) 1999-02-08 2000-08-10 Chiron Corporation Fibroblast growth factor receptor-immunoglobulin fusion
US7491509B2 (en) 2003-02-03 2009-02-17 Fraunhofer Usa, Inc. System for expression of genes in plants
US7692063B2 (en) * 2002-11-12 2010-04-06 Ibio, Inc. Production of foreign nucleic acids and polypeptides in sprout systems
US20060024272A1 (en) * 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon
EP2173377B1 (en) * 2007-06-26 2017-11-29 University of Miami Antibody-endostatin fusion protein and its variants
WO2011050311A1 (en) 2009-10-22 2011-04-28 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of endostatin peptides for the treatment of fibrosis
CN106478776A (zh) * 2011-07-19 2017-03-08 特拉索斯创新公司 抗纤维化肽及其在用于治疗以纤维化为特征的疾病和病症的方法中的用途
AU2016270428B2 (en) 2015-06-05 2020-11-26 Musc Foundation For Research Development Endostatin fragments and variants for use in treating fibrosis

Similar Documents

Publication Publication Date Title
JP2018524019A5 (enExample)
JP2015505299A5 (enExample)
RS58436B1 (sr) Stabilizovani rastvorljivi pre-fuzioni rsv f polipeptidi
JP2009540801A5 (enExample)
JP2018537087A5 (enExample)
WO2015005500A1 (en) Virus like particle comprising pd-1 antigen or pd-1 ligand antigen
JP2017506886A5 (enExample)
JP2014525239A5 (enExample)
RU2014126587A (ru) Химерная частица hpv
JP2024180560A5 (enExample)
JP2015509506A5 (enExample)
WO2017207480A1 (en) Stabilized pre-fusion rsv f proteins
TW202130363A (zh) 變異型rsv f蛋白質及其利用
JP2014519817A5 (enExample)
WO2022127825A1 (zh) 针对新型冠状病毒感染的疫苗组合物
CN103184230B (zh) 一种融合蛋白基因TAT-sVP7及其应用
CN108727503A (zh) VZV重组gE-鞭毛素融合蛋白及其制备方法和应用
US9925259B2 (en) Immunogenic polypeptide surface layer-expressing bifidobacterium
JP2018533908A5 (enExample)
JP2016521566A5 (enExample)
JP2015536347A5 (enExample)
JP2010514698A5 (enExample)
CN113430178B (zh) 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用
CN103102418B (zh) 粒细胞集落刺激因子(G-CSF)及其突变体(mG-CSF)与人血清白蛋白第三结构域(3DHSA)的融合蛋白及应用
Elkins et al. Plant production and functional characterization of catfish interleukin-22 as a natural immune stimulant for aquaculture fish